Role of pegylated liposomal doxorubicin in ovarian cancer. [electronic resource]
Producer: 20050208Description: 10-8 p. digitalISSN:- 0090-8258
- Antibiotics, Antineoplastic -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Ovarian Neoplasms -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.